Explore expert insights on managing adverse events in advanced breast cancer treatments targeting the PI3K/AKT/PTEN pathway.
Insights in PI3K/AKT/PTEN Pathway Breast Cancer: A Multidisciplinary Discussion on Adverse Event Management
Explore expert insights on managing adverse events in advanced breast cancer treatments targeting the PI3K/AKT/PTEN pathway.
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts NDA for Zanzalintinib Plus Atezolizumab in Pretreated mCRC
2
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
3
Retrospective, Real-World Analysis Shows Improved OS With Apalutamide Over Darolutamide in mCSPC
4
Five Under 5: Top Oncology Videos for the Week of 1/25
5